<?xml version="1.0" encoding="UTF-8"?>
<!--generator='jetpack-16.5-a.1'-->
<!--Jetpack_Sitemap_Buffer_News_XMLWriter-->
<?xml-stylesheet type="text/xsl" href="//medicinacardiometabolica.com/news-sitemap.xsl"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd">
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/10/mcm-rigidez-arterial-dia-41/</loc>
  <lastmod>2026-11-10T22:24:09Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Rigidez arterial: mecanismos, medición y pronóstico &amp;#124; Medicina Cardiometabólica · Día 41</news:title>
   <news:publication_date>2026-11-10T22:24:09Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/10/endo-supresion-gh-glucosa-oral-dia-41/</loc>
  <lastmod>2026-11-10T22:22:18Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Supresión de GH con glucosa oral en acromegalia &amp;#124; Endocrinología · Día 41</news:title>
   <news:publication_date>2026-11-10T22:22:18Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/10/cardio-tercer-ruido-s3-dia-41/</loc>
  <lastmod>2026-11-10T22:20:29Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Tercer ruido cardiaco: mecanismo y significado clínico &amp;#124; Cardiología · Día 41</news:title>
   <news:publication_date>2026-11-10T22:20:29Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/10/epoc-examen-fisico/</loc>
  <lastmod>2026-11-10T22:21:02Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>EPOC: examen físico y signos de atrapamiento aéreo</news:title>
   <news:publication_date>2026-11-10T22:19:13Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/10/mi-perfil-coagulacion-tp-inr-ttpa-dia-41/</loc>
  <lastmod>2026-11-10T22:18:15Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Perfil de coagulación: TP, INR y TTPa &amp;#124; Medicina Interna · Día 41</news:title>
   <news:publication_date>2026-11-10T22:18:15Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/10/eeuu-314-medicare-zapatos-pie-diabetico/</loc>
  <lastmod>2026-11-10T16:23:58Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Zapatos y plantillas para pie diabético: ¿los cubre Medicare?</news:title>
   <news:publication_date>2026-11-10T16:23:58Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/10/aha-2026-ensayos-optimal-stroke-zeus-lpa-horizon-survodutide/</loc>
  <lastmod>2026-11-10T11:14:19Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>AHA 2026: los ensayos que cierran el año — OPTIMAL-STROKE a 120 mmHg, ZEUS y Lp(a)HORIZON neutros, survodutide seguro</news:title>
   <news:publication_date>2026-11-10T11:13:22Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/09/mcm-estres-oxidativo-vascular-dia-40/</loc>
  <lastmod>2026-11-09T22:23:20Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Estrés oxidativo vascular, hiperglucemia y dislipidemia &amp;#124; Medicina Cardiometabólica · Día 40</news:title>
   <news:publication_date>2026-11-09T22:16:03Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/09/endo-curva-tolerancia-oral-glucosa-dia-40/</loc>
  <lastmod>2026-11-09T22:14:02Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Curva de tolerancia oral a la glucosa: indicaciones y lectura &amp;#124; Endocrinología · Día 40</news:title>
   <news:publication_date>2026-11-09T22:14:02Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/09/cardio-desdoblamiento-paradojico-s2-dia-40/</loc>
  <lastmod>2026-11-09T22:12:05Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Desdoblamiento paradójico del segundo ruido y sus causas &amp;#124; Cardiología · Día 40</news:title>
   <news:publication_date>2026-11-09T22:12:05Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/09/mi-proteinas-totales-albumina-dia-40/</loc>
  <lastmod>2026-11-09T22:09:56Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Proteínas totales y albúmina en el hospitalizado &amp;#124; Medicina Interna · Día 40</news:title>
   <news:publication_date>2026-11-09T22:09:56Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/09/atelectasia-sindrome-clinico/</loc>
  <lastmod>2026-11-09T22:09:42Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Atelectasia: síndrome clínico, signos y su LR</news:title>
   <news:publication_date>2026-11-09T22:09:42Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/09/eeuu-313-creatina-monohidrato-vs-hcl/</loc>
  <lastmod>2026-11-09T16:24:15Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Creatina monohidrato vs creatina HCl: cuál es mejor, dosis, efectos secundarios y precio (2026)</news:title>
   <news:publication_date>2026-11-09T16:23:56Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/09/dispositivos-insuficiencia-cardiaca-dai-resincronizacion-fevi-qrs-esc-2026/</loc>
  <lastmod>2026-11-09T11:26:07Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Dispositivos en insuficiencia cardíaca: criterios de DAI y resincronización, umbrales de FEVI y QRS (ESC 2026)</news:title>
   <news:publication_date>2026-11-09T11:23:11Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/08/mcm-disfuncion-endotelial-oxido-nitrico-dia-39/</loc>
  <lastmod>2026-11-08T22:13:37Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Disfunción endotelial y pérdida de óxido nítrico &amp;#124; Medicina Cardiometabólica · Día 39</news:title>
   <news:publication_date>2026-11-08T22:13:37Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/08/neumotorax-semiologia-signos/</loc>
  <lastmod>2026-11-08T22:14:33Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Neumotórax: semiología y signos de gravedad</news:title>
   <news:publication_date>2026-11-08T22:13:03Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/08/endo-prueba-estimulacion-trh-dia-39/</loc>
  <lastmod>2026-11-08T22:12:08Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Prueba de estimulación con TRH: su lugar limitado en tiroides hoy &amp;#124; Endocrinología · Día 39</news:title>
   <news:publication_date>2026-11-08T22:12:08Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/08/cardio-desdoblamiento-fisiologico-s2-dia-39/</loc>
  <lastmod>2026-11-08T22:10:37Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Desdoblamiento fisiológico del segundo ruido con la respiración &amp;#124; Cardiología · Día 39</news:title>
   <news:publication_date>2026-11-08T22:10:37Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/08/mi-patron-hepatocelular-colestasico-dia-39/</loc>
  <lastmod>2026-11-08T22:09:05Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Patrón hepatocelular versus colestásico en el perfil hepático &amp;#124; Medicina Interna · Día 39</news:title>
   <news:publication_date>2026-11-08T22:09:05Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/08/eeuu-312-medicare-rehabilitacion-cardiaca/</loc>
  <lastmod>2026-11-08T16:20:40Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>¿Cubre Medicare la rehabilitación cardíaca? Requisitos y copagos</news:title>
   <news:publication_date>2026-11-08T16:20:40Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/08/pelacarsen-lpa-horizon-radar/</loc>
  <lastmod>2026-11-08T11:27:07Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Pelacarsen y Lp(a): Radar cardiometabólico 8 nov</news:title>
   <news:publication_date>2026-11-08T11:27:07Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/08/antagonistas-receptor-mineralocorticoide-insuficiencia-cardiaca-fevi-dosis-control-potasio/</loc>
  <lastmod>2026-11-08T11:11:44Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Antagonistas del receptor mineralocorticoide en insuficiencia cardíaca: cuál elegir según la FEVI, dosis y control de potasio (ESC 2026)</news:title>
   <news:publication_date>2026-11-08T11:11:44Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
</urlset>